Evidence map›Paper›PMID 29291372›Full record

ArticleJournal of medicinal chemistry2018

Design, Synthesis, and in Vitro and in Vivo Evaluation of Ouabain Analogues as Potent and Selective Na,K-ATPase α4 Isoform Inhibitors for Male Contraception.

Shameem Sultana Syeda, Gladis Sánchez, Kwon Ho Hong, Jon E Hawkinson, Gunda I Georg, Gustavo Blanco

Open access · greenAbstract read
In one paragraph

Article in Journal of medicinal chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Strategies to Develop Na,K-ATPase-α4 Inhibitors as Male Contraceptives.International journal of molecular sciences · 2025
    Article
  4. Article
  5. Molecular Structure of the NaInternational journal of molecular sciences · 2024
    Article
  6. The uniqueness of on-demand male contraception.Molecular aspects of medicine · 2024
    Review
  7. Article
  8. Non-Hormonal Contraception.Journal of clinical medicine · 2023
    Review
  9. Update on Novel Hormonal and Nonhormonal Male Contraceptive Development.The Journal of clinical endocrinology and metabolism · 2021
    Review
  10. Toxins · 2021
    Review
  11. NaMolecules (Basel, Switzerland) · 2021
    Review
  12. Review
  13. Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Shameem Sultana SyedaDepartment of Medicinal Chemistry and Institute for Therapeutics Discovery and Development, College of Pharmacy , University of Minnesota , Minneapolis , Minnesota 55414 , United States.
Gladis SánchezDepartment of Molecular and Integrative Physiology , University of Kansas Medical Center , Kansas City , Kansas 66160 , United States.
Kwon Ho HongDepartment of Medicinal Chemistry and Institute for Therapeutics Discovery and Development, College of Pharmacy , University of Minnesota , Minneapolis , Minnesota 55414 , United States.
Jon E HawkinsonDepartment of Medicinal Chemistry and Institute for Therapeutics Discovery and Development, College of Pharmacy , University of Minnesota , Minneapolis , Minnesota 55414 , United States.
Gunda I GeorgDepartment of Medicinal Chemistry and Institute for Therapeutics Discovery and Development, College of Pharmacy , University of Minnesota , Minneapolis , Minnesota 55414 , United States.ORCID 0000-0002-8900-9460
Gustavo BlancoDepartment of Molecular and Integrative Physiology , University of Kansas Medical Center , Kansas City , Kansas 66160 , United States.
University of Minnesota · USUniversity of Kansas Medical Center · US

Funding

Targeting Na,K-ATPase alpha4 for male contraceptionR01HD102623 · NICHD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI BLANCO, V GUSTAVO, GEORG, GUNDA I. · 2020 to 2024
$2.6M
Inhibitors of Na,K-ATPase alpha4 as male contraceptivesU01HD080423 · NICHD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI BLANCO, V GUSTAVO · 2014 to 2016
$727k
Inhibitors of Na,K-ATPase alpha4 as male contraceptivesR01HD080423 · NICHD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI BLANCO, V GUSTAVO · 2017 to 2018
$482k
NICHD NIH HHS HHSN275201300017CNICHD NIH HHS HHSN275201300017INICHD NIH HHS R01 HD080423NICHD NIH HHS R01 HD102623NICHD NIH HHS U01 HD080423
6 · The paper itself

Abstract

Na,K-ATPase α4 is a testis-specific plasma membrane Na

Indexed as

AnimalsContraceptionDrug DesignEnzyme InhibitorsHumansIsoenzymesMaleMiceOuabainSodium-Potassium-Exchanging ATPaseSpermatozoaSperm MotilityStructure-Activity RelationshipTestisEnzyme InhibitorsIsoenzymesOuabainSodium-Potassium-Exchanging ATPase

Identifiers

PMID29291372
PMCPMC5846083
OpenAlexW2782331022

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.